Kids, colds, and complement: paroxysmal cold hemoglobinuria.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. How Severe is Severe Enough? Organ Failure Rather Than Anemia Severity as a Potential Threshold for Complement Inhibition in Pediatric Paroxysmal Cold Hemoglobinuria: A Case Report.Case reports in pediatrics · 2026
   Article
2. A Case of Childhood Severe Paroxysmal Cold Hemoglobinuria with Acute Renal Failure Successfully Treated with Plasma Exchange and Eculizumab.Case reports in pediatrics · 2022
   Article
3. A Case of Paroxysmal Cold Hemoglobinuria Possessing Moderate Paroxysmal Nocturnal Hemoglobinuria-Type Erythrocytes.The American journal of case reports · 2021
   Article
4. Allo-anti-M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion.Transfusion · 2021
   Article
5. Paroxysmal cold hemoglobinuria successfully treated with complement inhibition.Blood advances · 2019
   Article

Corrections and comments

• Comment on
  Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as